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Abstract: Opioids are clinically important in the alleviation of pain. An
undesirable side effect of opioids is depression of breathing. Data from
isolated preparations suggest this effect is due to attenuation of discharge
activity of neurons in the pre-Bötzinger complex (preBötzC), a medullary area
with respiratory rhythmogenic properties. The purpose of this study was to
examine how [d-Ala(2),N-Me-Phe(4),Gly(5)-ol]-enkephalin (DAMGO), a μopioid receptor agonist, affected breathing after injection into the presumed
preBötzC of the adult awake goat. We hypothesized that DAMGO would cause
breathing to decrease and become irregular when injected into the presumed
preBötzC and the surrounding region of the conscious animal. We further
hypothesized that ventilatory sensitivity to CO2 and hypoxia would be blunted
after the injection of DAMGO. Microtubules were bilaterally implanted into the
presumed preBötzC of 10 adult female goats. After recovery from the
surgery, DAMGO (0.5–10 μl, 1 nM–10 μM) was injected into the presumed
preBötzC during the awake state. DAMGO had no effect on pulmonary
ventilation [inspiratory minute ventilation (V̇i)], respiratory rhythm and
pattern, the activation pattern of inspiratory and expiratory muscles, or
arterial blood gases during eupneic breathing conditions (P > 0.10). However,
DAMGO attenuated (P < 0.05) the evoked increase in breathing frequency
when inspired CO2 was increased, and DAMGO attenuated the V̇i response to
reduction of inspired O2 to 10.8% (P < 0.05). We conclude that our data do
not provide support for the concept that in awake mammals opioid depression
of breathing is due to a directed action of opioids on preBötzC neurons.
Keywords: chemosensitivity, [d-Ala(2),N-Me-Phe(4),Gly(5)-ol]-enkephalin
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Opioids are routinely used in the treatment of pain, coughing,
and smooth muscle spasticity. However, their therapeutic uses are
limited by respiratory complications, including depression of
respiratory frequency (f), tidal volume (Vt), and sensitivity to CO2 and
hypoxia.24,32 Accordingly, considerable research efforts have been
focused on understanding the opioid influence on respiratory control.
The μ- and δ-opioid receptors are found throughout many of the
respiration-related regions of the medulla;2,4,7,14,16 thus it is
conceivable that the opioid effect on breathing is through the
depression of neurons at multiple sites within the neural network that
controls breathing. One apparent primary site that opioids affect is the
pre-Bötzinger complex (preBötzC),1,3,5,20,22 an area thought to be
critical in generating inspiratory muscle activity.9,10 Indeed, opioids
cause quantal slowing of respiratory rhythm in a brain stem-spinal
cord preparation containing both the preBötzC and the more rostrally
located parafacial respiratory group (pFRG),3,10,18 which is
hypothesized to generate expiratory muscle activity.10,11 However,
when [d-Ala(2),N-Me-Phe(4),Gly(5)-ol]-enkephalin (DAMGO) is
applied to a more isolated preparation that likely lacks a functional
pFRG, there is a further pronounced slowing of respiratory rhythm.18,22
Thus it is apparent that in an in vitro preparation opioids exert an
important influence on the preBötzC, and consequently the resultant
respiratory rhythm.
The effect of opioids on preBötzC neurons in vivo is unclear. In
one in vivo study on both anesthetized and unanesthetized
decerebrate adult cats, intravenous injections of an opioid had no
direct opioid-mediated membrane effects on inspiratory or expiratory
bulbospinal neurons in the ventral respiratory group; thus the
observed slowing of respiratory rhythm does not appear to be related
to opioid postsynaptic actions on these types of neurons.15
Accordingly, it is possible that “other candidate sites of opiatemediated rhythm slowing, in particular the preBötzC and the rostral
pons, are implicated from the pattern of slowing”.15 However, in
studies on anesthetized rats and decerebrate dogs, injection of μopioids into the preBötzC increased respiratory rate.16,21
We are not aware of any published reports on the effect of
DAMGO injected into the preBötzC region of freely behaving, awake
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mammals. Therefore, the purpose of the present study was to address
this issue in awake adult goats that had been chronically implanted
with microtubules within the preBötzC region. We hypothesized that
because of the known respiratory depressant effects of opioids,
together with the observed effects of the aforementioned in in vitro
preparations, DAMGO will cause breathing to decrease and become
irregular when injected into the presumed preBötzC region of the
conscious animal. We further hypothesized that because opioids are
known to blunt breathing during hypercapnia and hypoxia,24,32 DAMGO
injections into the preBötzC region of the conscious animal will cause
the breathing responses to be blunted during these conditions as well.

Methods
Data were obtained on four groups (group 1, n = 7; group 2, n
= 3; group 3, n = 1, group 4, n = 7) of adult female goats weighing
43.3 ± 2.4 kg. Goats in groups 1–3 were utilized for physiological
studies, and those in group 4 were utilized solely for histology on the
medulla. Goats were used for this study because this species has a
regular pattern of inspiratory (diaphragm) and expiratory (abdominal
oblique) muscle activity during eupnea.13,33,34 Goats were housed and
studied in an environmental chamber with a fixed ambient
temperature and photoperiod. All goats were allowed free access to
hay and water, except for periods of study. The goats were trained to
stand comfortably in a stanchion during periods of study. All aspects of
the study were reviewed and approved by the Medical College of
Wisconsin Animal Care Committee before the studies were initiated.

Surgical procedures.
Before all surgery, goats were anesthetized with a combination
of ketamine and xylazine (15 mg/kg and 1.25 mg/kg, respectively),
intubated, and mechanically ventilated with 1.5% halothane in 100%
O2. All surgeries were performed under sterile conditions. Each goat
underwent an initial instrumentation surgery in which electromyogram
(EMG) electrodes were implanted into the diaphragm (Dia) and
abdominal internal and external oblique (Abd) muscles. The purpose of
obtaining Dia and Abd muscle activity (inspiratory and expiratory
muscles, respectively) was to determine whether a potential reduction
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in Dia activity after the injection of DAMGO into the preBötzC would be
compensated by an increase in expiratory activity to result in a
partially passive inspiration.9 This type of change occurs after
attenuation of preBötzC activity via injections of a neurotoxin into the
preBötzC.34 A 5-cm segment of each carotid artery was dissected from
the vagus nerve and elevated subcutaneously for eventual insertion of
a catheter. Ceftiofur sodium (Naxcel; 8 mg/kg im) was administered
daily for 1 wk postoperatively to minimize infection.
After at least 2 wk of recovery, goats underwent another
surgery for the purpose of bilaterally implanting 70-mm-long (OD =
1.27 mm, ID = 0.84 mm) stainless steel microtubules into the
presumed preBötzC area. An occipital craniotomy was created, and the
dura mater was excised to expose the posterior cerebellum and the
dorsal aspect of the medulla for visualization of obex. In goats of
groups 1 and 2, the microtubules were placed 2–3 mm rostral to obex,
4–5 mm lateral to the midline, and 4–6 mm from the dorsal surface.
In the goat of group 3, the microtubules were 1 mm rostral to obex, 6
mm lateral to the midline, and 3 mm from the dorsal surface. The
microtubules were chronically fixed with stainless steel screws and
dental acrylic.
After brain surgery, the goats were visually monitored
continuously by laboratory personnel for at least 6 h, or until they
reached stable conditions, after which they were checked hourly for
the next 24 h. Buprenorphrine hydrochloride (Buprenex; 0.005 mg/kg)
was administered for pain. After the brain surgery, the goats were
placed on a regimen of medication to minimize infection
(chloremphenicol 20 mg/kg iv, 3 times daily for 3 days) and swelling
(dexamethasome iv, 3 times daily for 7 days, starting with 0.4 mg/kg
and decreasing to 0.05 mg/kg). Everyday thereafter the goats were
medicated with ceftiofur sodium (4 mg/kg im) and gentamicin (6
mg/kg im).

Experimental procedures and protocols.
Studies commenced after a minimum 2-wk period of recovery
from the brain surgery. Before the present study, group 1 animals
were used to study respiratory chemosensitivity in the preBötzC by
way of a microdialysis-induced focal acidosis.12 For the present study,
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all goats were monitored over a 30-min room air control period and
arterial blood was sampled. DAMGO was then injected bilaterally into
the preBötzC of awake goats over a period of 30 s. On separate days,
group 1 animals had 0.5 μl of 1 nM DAMGO injected into the preBötzC,
as well as 0.5 and 10 μl of 100 nM DAMGO. Group 2 animals had 0.5
and 10 μl of 1 and 10 μM DAMGO injected into the preBötzC. The
volumes injected were chosen to affect either a small or a more
expanded area of the preBötzC region. Physiological variables (see
below) were monitored for 30 min after the injection during eupneic
conditions, and arterial blood was sampled over the last 2 min of the
study. The goat's sensitivity to either CO2 or hypoxia was assessed
immediately after the 30-min study period. Previous studies have
found effects on physiological function over the time frame of our
protocol.30,32 On separate days, CO2 and hypoxia sensitivity were also
assessed without prior DAMGO injection. On any single day, there was
only one bilateral injection of DAMGO. Hypoxia studies were never
completed on consecutive days. No more than two CO2 studies were
completed on a single day.
CO2 sensitivity was assessed by sequentially increasing inspired
CO2 to 3%, 5%, and 7% at 5-min intervals. Arterial blood was
sampled over the last 2 min of each level of inspired CO2. Hypoxia
sensitivity was assessed by decreasing inspired O2 to 10.8% for 30
min, followed by a 15-min room air recovery. Arterial blood was
sampled during minutes 5 and 25 of hypoxia and over the last 2 min of
the recovery period.

Glutamate receptor agonist injections.
A glutamate receptor agonist applied to the preBötzC elicits a
unique tachypneic and dysrhythmic breathing response.13,17,25,31,34
Accordingly, after completion of the DAMGO injection studies reported
here, the irreversible glutamate receptor agonist ibotenic acid (IA) was
injected through the microtubules into the tissue of the first three
groups of goats. IA was chosen for injection because in addition to
providing evidence that the microtubules were correctly placed, the
neurotoxic effect of IA also incrementally destroyed the presumed
preBötzC. This destruction allowed for the subsequent study of the
capability of the respiratory network to provide a normal respiratory
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rhythm and pattern after near-total elimination of the preBötzC area.13
The experimental design consisted of injection of a series of
incremental sequential volumes of IA (50 mM) that started with 0.5 μl
and increased to 10 μl. Each injection was separated by 1 wk. After a
15-min eupneic control period, a unilateral injection of IA was made
into the preBötzC through the microtubule. Physiological variables
were monitored for 1 h, and then an identical injection was made into
the contralateral microtubule, except that the contralateral injection of
10 μl was made 1 wk later. The 10-μl injections were separated by 1
wk because of the severe effects observed in a previous study when
10-μl injections were made bilaterally on the same day.34

Physiological variables.
During every study, inspiratory flow (Vi) was measured with a
pneumotach by attaching a breathing valve to a custom-fitted mask
secured to the goat's muzzle. Expired air was collected in a
spirometer. The volume of expired air and the concentrations of CO2
and O2 in the air were measured, and from these measurements O2
consumption and CO2 excretion were computed. Mean arterial blood
pressure (MABP) and heart rate (HR) were measured with a Statham
transducer connected via tubing to a catheterized carotid artery. The
proximal ends of the EMG electrodes were connected via microclips to
a Grass recorder for signal filtering at a band pass of 3–500 Hz. The
airflow and raw EMG signals were sent for display, digital recording,
and analysis to a CODAS computer data acquisition system at a
sampling rate of 250 Hz. Arterial blood was sampled in duplicate for
blood gas and pH measurements. Rectal temperature was monitored
at regular intervals.

Histological studies.
As stated above, after completion of the present study the
animals were further studied to determine the effect of neurotoxin
(IA)-induced destruction of the preBötzC area.13 Accordingly, it was
impossible to histologically verify the presence of μ-opioid receptors
within the preBötzC of these animals. Therefore, to confirm the
presence of μ-opioid receptors within the presumed preBötzC area, an
area known to have a high density of neurokinin-1 (NK1)-expressing
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neurons,13,33 two unoperated control animals were euthanized
(Beuthanasia), perfused with physiological buffer solution, and fixed
with 4% paraformaldehyde. The medulla was excised and placed in a
4% paraformaldehyde solution for 24–48 h and then placed in a 30%
sucrose solution. The medulla was then frozen and serial sectioned (10
or 25 μm) in a transverse plane, and the sections were adhered to
chrome alum-coated slides. Immunohistochemistry for μ-opioid
receptors was determined by complexing rabbit anti-μ-opioid receptor
antibody (primary antibody, 1 μl antibody to 1,000 μl 0.2% Triton X100 in physiological buffer solution; Chemicon International) with
biotinylated anti-mouse antibody (secondary antibody, 1 μl antibody to
60 μl 0.2% Triton X-100 in physiological buffer solution).
Four additional unoperated control goats were euthanized, and
the medulla was extracted, transversely sectioned (25 μm), and
prepared for immunohistochemistry to determine the profile of NK1
receptor (NK1R)-expressing neurons in the ventral medulla. Rabbit
anti-NK1R antibody (primary antibody, 1 μl antibody to 3,000 μl 0.2%
Triton X-100 in physiological buffer solution, blocked with 5% normal
horse serum and 0.2% Triton X-100 in physiological buffer solution)
was complexed with biotinylated anti-mouse antibody (secondary
antibody, 1 μl antibody to 60 μl 0.2% Triton X-100 in physiological
buffer solution). After the antibody-antigen complexes for both μopioids and NK1 were incubated, they were localized by avidin (Vector
ABD Elite) and developed with diaminobenzoate.
A seventh unoperated goat was euthanized, and the extracted
and preserved medulla was sectioned in the sagittal plane. The
sections were Nissl stained for visualization of the rostral-caudal
orientation of major respiratory nuclei in goats.
NK1- and μ-opioid-immunoreactive neurons were visualized
under a microscope and were counted over the distance 2.0–4.6 mm
rostral to obex. Counts were made in the nucleus ambiguus and in an
area of 1.5 × 1.5 mm just ventral to the nucleus ambiguus that we
presume to include the preBötzC. Counts were also made in a 1.5 ×
1.5-mm area ventral to the presumed preBötzC.
Finally, after the physiological studies were completed in goats
of groups 1 and 2 they were euthanized, and then the medulla was
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harvested and processed (Nissl stain) to verify the correct placement
of the microtubules within the preBötzC area.

Data analysis.
Respiratory airflow and EMG signals were processed and
analyzed (Windaq, DATAQ Instruments). Raw EMG data were full-wave
rectified and passed through a moving time average (time constant
0.1 s) to obtain an integrated EMG signal. Pulmonary ventilation
[inspiratory minute ventilation (V̇i); l/min], f (breaths/min), tidal
volume (Vt; l), and Dia and Abd muscle activity (mV) were computed
on a breath-by-breath basis and averaged into 5-min bins. All bins
were divided by the 15-min control mean for normalization (% of
control). Arterial blood was sampled in duplicate, and arterial partial
pressure of O2 (PaO2; Torr), arterial partial pressure of CO2 (PaCO2;
Torr), and pH (pH units) (model 248 Rapid Lab) were averaged.
Breath-to-breath variations in breathing parameters were quantified
by determining the coefficient of variation (CV) over all breaths at 5min intervals. The data from all trials per animal were averaged. For
group 1 animals, the mean data were then statistically analyzed by
one- or two-way ANOVA for repeated measures to determine
significance (P ≤ 0.05) of the physiological variables and expressed as
SE about the mean. Individual significant differences were examined
with the Bonferroni post hoc test. No statistical analysis was performed
on group 2 and 3 animals, given the small sample size.

Results
Histology.
Shown in Fig. 1A is a parasagittal section of a control goat's
medulla that illustrates the approximate location of the presumed
preBötzC relative to the nucleus ambiguus and the facial nucleus.
Figure 1B shows a transverse section of a goat's medulla (3 mm
rostral to obex) that is stained with the secondary but not the primary
antibody (negative control). Shown in Fig. 1, C and D, are transverse
sections of a control goat's medulla that illustrate μ-opioid- and NK1expressing neurons 2.9 and 3.1 mm rostral to obex, respectively.
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Fig. 1. Identification of neuronal groups in the medulla of goats. A: parasagittal Nisslstained section (×1) 4.9 mm lateral to the midline that identifies the nucleus
ambiguus (NA), the facial nucleus (FN), and the approximate location of the presumed
pre-Bötzinger complex (preBötzC) (marked by box) which is ∼3.0 mm rostral to obex.
D, dorsal; V, ventral; R, rostral; C, caudal. B: transverse section (×4) of a goat 3.0
mm rostral to obex stained with the secondary, but not the primary, antibody
(negative control). C and D: transverse sections (×4) 2.9 and 3.1 mm rostral to obex
immunostained to identify μ-opioid and neurokinin-1 (NK1) receptor-expressing
neurons respectively. Insets in B–D: ×40 images of single control and μ-opioid- and
NK1 receptor-expressing neurons, respectively. Dotted circle and square box in B–D
demarcate NA and presumed preBötzC, respectively. L, lateral; M, medial.

As in a previous study,34 we found in four control goats a
distinct increase (P < 0.001) in the number of NK1-positive neurons in
a 1.5 × 1.5-mm region just ventral to the nucleus ambiguus and 2.5–
3.5 mm rostral to obex (Fig. 2A). We presume the preBötzC is included
in this region of the goat medulla. NK1-positive neurons were also
present in the nucleus ambiguus (Fig. 2B) and ventral to the presumed
preBötzC (Fig. 2C), but there was no distinct rostral-caudal increase in
NK1-positive neurons in these areas. In the presumed preBötzC region
2.5–3.5 mm rostral to obex, there was an abundance of μ-opioidimmunoreactive neurons (Fig. 2D), but there was no rostral-caudal
change in the μ-opioid profile. There were many immunoreactive μopioid neurons in the nucleus ambiguus (Fig. 2E) and ventral to the
presumed preBötzC (Fig. 2F).
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Fig. 2. Quantization of NK1- and μ-opioid-expressing neurons 2–4.6 mm rostral to
obex in the ventral medulla of goats. A: no. of NK1-immunoreactive neurons for a 1.5
× 1.5-mm region just ventral to nucleus ambiguus (NA); high density of positive
neurons 2.5–3.5 mm rostral to obex indicates that this region likely includes the
preBötzC. B and C: no. of NK1-positive neurons in NA and ventral to presumed
preBötzC, respectively. D–F: no. of μ-opioid-positive neurons for presumed preBötzC,
NA, and area ventral to preBötzC, respectively. Note that there are both NK1- and μopioid-positive neurons in all 3 regions, but only presumed preBötzC shows a rostralcaudal region of increased density of NK1-positive neurons.

Figure 3 shows a hemisection of one goat's medulla 3.2 mm
rostral to obex. The microtubule tract is visible 4.45 mm from the
midline and 3.35 mm from the ventral surface. For group 1 and 2
goats, the average (±SE) placements were 2.9 ± 0.6 mm rostral to
obex, 4.6 ± 0.2 from the midline, and 3.4 ± 0.3 mm from the ventral
surface.

Fig. 3. In group 1 and 2 goats, microtubules were placed just ventral to the dorsal
edge of NA into the preBötzC. Left hemisection is a Nissl stain of a control goat's
medulla 3 mm rostral to obex, and the box outlines presumed preBötzC. Right
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hemisection is a Nissl stain of a goat with bilaterally implanted microtubules. The tract
of the microtubule is indicated by the area devoid of tissue. The extensive tissue
disruption ventral to the tip of the microtubule is due primarily to the neurotoxin
injected over weeks after completion of the [d-Ala,2 N-Me-Phe,4 Gly5-ol]-enkephalin
(DAMGO) studies. This conclusion is based on our laboratory's previous finding (see
Figs. 4 and 5 in Ref. 8) in goats in which we followed the same design as in the
present study and found that the tissue damage ventral to the microtubule implanted
into the raphe nucleus was 5 times greater in goats that had an injection of ibotenic
acid (IA) than in goats that did not have an injection of IA.

Glutamate injections confirm correct placement of
microtubules.
Confirmation of correct microtubule placement in the goats
studied here was provided by the characteristic tachypnea (Figs. 4 and
5B) in the goats when IA was injected into the preBötzC in increasing
volumes at weekly intervals after the completion of the DAMGO
studies. As the volume of the bilateral injections increased from 0.5 to
5 μl, the tachypnea was dose dependent, increasing from 25% to
250% above control (P < 0.05), but the response to the unilateral 10μl injections was less than the response to the 5-μl injections (Fig. 4).
The reduced responses to 10 μl may have been a result of neuronal
destruction caused by the preceding injections. When IA was injected
into one goat in which the microtubules were implanted dorsal and
lateral to the preBötzC, no tachypnea was elicited (Fig. 4).

Fig. 4. Group (n = 10) average representation of the tachypnea induced by IA
injections into the preBötzC of awake goats (■). The 0.5-, 1.0-, and 5-μl injections
were bilateral, while the two 10-μl [left (L) and right (R) sides] injections were
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separated by 1 wk. All injections induced a significant (P < 0.05) tachypnea. We
speculate that the tachypnea is less at the two 10-μl injections because 1) the 10-μl
injections were unilateral 1 wk apart or 2) the 0.5-, 1.0-, and 5-μl injections had
destroyed a significant number of neurons. □, Data from 1 goat in which microtubules
were placed lateral and dorsal to preBötzC. f, Respiratory frequency.

Fig. 5. Inspiratory flow (Vi) and raw diaphragm (Dia) and external oblique abdominal
(Abd) muscle activity in an awake goat during control conditions (A and C) and after
injection of IA (B) or DAMGO (D and E) into presumed preBötzC. Note in all panels
that Dia activity is in phase with Vi and Abd activity occurs in intervals between Dia
activity. Also note that IA increased respiratory frequency but DAMGO had no effect on
respiratory frequency or pattern.

Physiological measurements during eupneic breathing
conditions.
In goats during eupnea in the awake state, the Dia contracts
throughout inspiration and the Abd contracts during the expiratory
period (Fig. 5, A and C). This muscle activation pattern was not altered
by injection of DAMGO into the presumed preBötzC (Fig. 5, D and E,
and Fig. 6). In group 1 goats, there were no significant effects on V̇i,
Dia and Abd muscle activity (Fig. 6), f, Vt, resting PaCO2, MABP, or HR
during eupneic breathing conditions after the 0.5 μl, 1 nM (n = 7, 8
trials), the 0.5 μl, 100 nM (n = 7, 13 trials), or the 10 μl, 100 nM (n =
7, 11 trials) bilateral DAMGO injections (P > 0.05). Similarly in group 2
goats, there was no consistent change beyond the variation during the
control periods in V̇i and Dia and Abd muscle activity after injection of
0.5 μl, 1 μM (Fig. 7); 10 μl, 1 μM; or 10 μl, 10 μM DAMGO. In this
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group of goats, there also were no changes in any measured
physiological variable after the DAMGO injections. In group 1 and 2
goats, there was no significant (P > 0.10) or notable change after the
DAMGO injections in the CV for all the measured physiological
variables. Finally, when DAMGO was injected into the goat with the
microtubules dorsal and lateral to the preBötzC, there was no effect on
any measured physiological variable (data not shown).

Fig. 6. Inspiratory minute ventilation (V̇i) and Dia and Abd muscle activity before and
after bilateral injection of 0.5 μl or 10 μl of 100 nM DAMGO into preBötzC of awake
goats. Injection time is indicated by vertical line. Data are expressed as % of control
(before injections) and are average values for group 1 goats (n = 7). There were no
statistically significant effects of the injections on V̇i or the activity of either muscle at
both volumes.
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Fig. 7. V̇i and Dia and Abd muscle activity before and after bilateral injection of 0.5 μl,
1 μM DAMGO into preBötzC area of awake goats. Injection time is indicated by vertical
line. Data are expressed as % of control (before injections) and are average values for
group 2 goats (n = 3). Values after injections did not consistently differ from the
variation during control conditions.

Physiological measurements during hypoxic breathing
conditions.
During hypoxia without prior injections of DAMGO, the hypoxic
(10.8% O2) ventilatory response consisted of a sharp, almost
immediate increase in breathing within the first 1–2 min of hypoxia,
followed by a ventilatory plateau for 6–8 min, and finally another
period of increased ventilation for the remainder of the hypoxic period
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(Fig. 8; Ref. 13). After the 10 μl, 100 nM DAMGO injection in group 1
goats, the ventilatory response was significantly decreased (P < 0.05)
from the control hypoxia study during the final 10 min of the hypoxic
response (Fig. 8). In other words, the effect of DAMGO was on the
third phase of the normal response to hypoxia. Also in group 2 goats,
the hyperpnea at 25 min of hypoxia was less than the control hypoxia
after prior injection of 0.5, 1 μM; 10 μl, 10 μM; and 10 μl, 10 μM
DAMGO (Fig. 9).

Fig. 8. Bilateral 10 μl, 100 nM DAMGO injection into the preBötzC of awake goats
significantly attenuated the ventilatory (V̇i) response during hypoxia (10.8% inspired
O2) (P = 0.001, n = 7, 5 trials). Data (on group 1 goats) were averaged in 1-min
intervals and expressed as % of control. Vertical lines delineate room air control,
hypoxia, and room air recovery. Asterisks at top indicate time points during hypoxia
significantly different (P < 0.05) between control and post-DAMGO responses.

Fig. 9. Bilateral injection of 3 different doses of DAMGO decreased the ventilatory (V̇i)
response to 10.8% O2 in group 2 goats. Individual data are presented for the 5th and
25th minutes of hypoxia.
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Physiological measurements during hypercapnic
breathing conditions.
When inspired CO2 was increased without prior injection of
DAMGO, there was an almost immediate increase in V̇i due to an
increase in Vt at 3% inspired CO2, and then an increase in f at 5% and
7% inspired CO2. In group 1 goats, the only significant effect on this
response was an attenuation of the tachypnea during 5% and 7% CO2
after the 0.5 μl, 100 nM DAMGO injection (Fig. 10). In group 2 goats,
there were no consistent effects on CO2 responses by the DAMGO
injections.

Fig. 10. The 0.5 μl, 100 nM injection of DAMGO significantly reduced the respiratory
frequency response during 5% and 7% CO2 (P = 0.028, n = 7, 7 trials). Data were
averaged in 1-min intervals and expressed as % of control. Dashed lines indicate the
start of each level of CO2. Asterisks denote time points during hypercapnia significantly
(P < 0.05) different between control and post-DAMGO conditions.

Discussion
Major conclusions.
In contrast to our first hypothesis, a bilateral injection of the μopioid receptor agonist DAMGO into the preBötzC of awake adult goats
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had no significant effect on respiratory rhythm or pattern during
eupneic conditions regardless of volume or concentration. However,
consistent with our second hypothesis, DAMGO did alter aspects of
breathing during hypoxic and hypercapnic conditions.

Anatomic and functional definition of the preBötzC.
Several studies have attempted to define the boundaries of the
preBötzC. Studies in adult rats found a distinct increase in the density
of NK1-positive neurons in an area just ventral to the nucleus
ambiguous.4,6,26,31 Data from other studies suggested that
somatostatin-positive neurons in this area defined the boundaries of
the preBötzC.26,28 To further explore “the necessary and sufficient
boundaries for a functional preBötzC,” studies were recently completed
on neonatal rat medullary slices of different thicknesses.22,23 The data
indicate that there is a core of rhythmogenic neurons 0.5 mm caudal
to the facial nucleus essential for respiratory rhythmogenesis, with
neurons caudal and rostral to the core that contribute to the eupneic
and sigh rhythms, respectively. Although these data define the
preBötzC in a neonatal rat, the exact boundary of the preBötzC, or
boundary of the medullary neurons responsible for the eupneic
respiratory rhythm, has not been established in adult mammals.
However, it is generally accepted that the preBötzC includes an area
ventral to the nucleus ambiguus that has a high density of NK1- and
somatostatin-expressing neurons.
Previous data from our laboratory,13,33 as well as data in Fig. 2
of the present study, substantiate a distinct increase in the density of
NK1-positive neurons 2.5–3.5 mm rostral to obex in goats. This area
of increased NK1-positive neurons is just ventral to the nucleus
ambiguus. Thus we implanted the microtubules 2.5–3.5 mm rostral
from obex and then advanced them to the ventral border of the
nucleus ambiguus and the dorsal border of the preBötzC (Fig. 3).
Functionally, the preBötzC has been defined by the distinct,
unique tachypneic and dysrhythmic response13,17,25,31,33 to glutamate
receptor agonist injections into the area of an increase in NK1Rpositive neurons.4,6,13,26,31,33 Indeed, weeks after the completion of the
DAMGO injections in the present group of goats, there was prominent
tachypnea and dysrhythmia when the glutamate receptor agonist and
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neurotoxin IA was injected through the microtubule into the region of
high-density NK1R-expressing neurons (Figs. 4 and 5). These findings
corroborate a previous study in which a profound tachypnea and
dysrhythmia were also observed after injection of IA in the presumed
preBötzC of awake goats.34 These functional data, and the abovementioned histological data, provide evidence of the presumed location
of the preBötzC in goats even though the exact boundaries have not
been established.

μ-Opioid receptor immunohistochemistry.
It has been well documented that μ-opioid receptors are widely
distributed throughout the ventral respiratory group and the
preBötzC.2,4,7,14,16 As stated above, after the completion of the present
study these goats were further used in studies that nearly destroyed
the entire presumed preBötzC. Accordingly, we did not immunostain
for the presence of μ-opioid receptors in these goats that received
DAMGO. Consequently, μ-opioid immunostaining was completed in two
unoperated control goats. Positive μ-opioid receptor staining was
found in the preBötzC (Fig. 1C and Fig. 2D) and in the nucleus
ambiguus (Fig. 2E) and the area ventral to the preBötzC (Fig. 2F).

Neurons exposed to DAMGO in the present study.
Accuracy in calculating the diffusion of substances injected into
the brain is dependent on the validity of several assumptions. The
validity of the assumption is a major issue, particularly, as pointed out
by Thorne et al.29 that “the intercellular spaces between neurons and
glia contain an amorphous, negatively charged extracellular matrix
(ECM) with the potential to shape and regulate the distribution of
many diffusing ions, proteins, and drugs.” This statement emphasizes
a limitation of the present study, specifically, that we do not have
definitive evidence of the diffusion of DAMGO and thus the neurons
affected by DAMGO. However, it is highly likely that the injected
DAMGO diffused to affect preBötzC neurons. This conclusion is based
on the finding that tachypnea and dysrhythmia occurred when a
glutamate receptor agonist was subsequently injected through the
microtubule into the tissue (Fig. 4). This unique response is
characteristic of activation of preBötzC neurons.13,17,25,31,33 It is also
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highly likely that preBötzC neurons were not selectively affected by the
DAMGO injections. This conclusion is based on the extensive tissue
damage (Fig. 3) and deficit in neurons (Table 2 in Ref. 13) beyond the
presumed preBötzC as a result of the injection of the neurotoxin days
after the DAMGO injections. The finding that the DAMGO injections
affected the responses to hypoxia and hypercapnia (Figs. 8–10) clearly
indicates that DAMGO diffused to affect neurons that are part of the
network controlling breathing. Therefore, we are confident that the
doses of DAMGO used in the present study were sufficient to affect
preBötzC rhythmogenic neurons, as well as neurons in the region
surrounding the preBötzC.

Effect of DAMGO during eupneic breathing conditions.
A bilateral injection of DAMGO into the preBötzC of awake adult
goats had no significant effect on respiratory rhythm or pattern during
eupneic breathing conditions. In agreement with our data, Montandon
and Horner19 recently showed that microdialysis of 100 μM fentanyl
into the preBötzC of awake adult rats had no effect on respiratory rate.
However, when they microdialyzed fentanyl in the anesthetized or
non-rapid eye movement (NREM) sleep states respiratory rate was
decreased 43% and 30%, respectively, but quantal slowing was not
observed. In contrast, Lonergan et al.16 found that 10 mM
endomorphin-1 microinjected into the preBötzC of anesthetized adult
rats increased respiratory rate by 16–45%. Similarly, Mustapic et al.21
found that 100 μM DAMGO injected into the preBötzC of adult
decerebrate dogs increased respiratory rate by 44%. In both the
studies of Montandon and Horner19 and Mustapic et al.,21 intravenous
administration of a μ-opioid agonist depressed breathing. None of the
in vivo studies on adult mammals has found quantal slowing of
respiratory rate when a μ-opioid was administered to the preBötzC.
Accordingly, even though there is no consensus among these in vivo
studies on adult mammals, it seems unlikely that the preBötzC is the
primary site within the brain for the depression of breathing that
occurs with intravenous administration of opioids.
The findings summarized above for adult in vivo conditions
contrast with the data from several in vitro studies. Indeed, opioids
cause quantal slowing of respiratory rhythm in a brain stem-spinal
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cord preparation containing the preBötzC and the preinspiratory
neurons of the more rostral pFRG3,10,18 hypothesized to generate
expiratory muscle activity.11,12 However, when DAMGO is applied to a
more isolated preparation that lacks a functional pFRG, there is a more
pronounced slowing of respiratory rhythm.18,22 From these data, Mellen
et al.18 concluded “these findings suggest that opioid-induced quantal
slowing results from transmission failure of rhythmic drive from pre-I
neurons to preBötzC I networks, depressed below threshold for
spontaneous rhythmic activity.”
We are not aware of a definitive explanation for the differences
in the effects of DAMGO in in vivo adult mammals and the in vitro
neonatal rat preparation. One possible explanation, particularly in the
awake goat, is that the respiratory control network was largely intact
(except for neurons destroyed by the implanted microtubules). Thus
sources of excitatory inputs to the preBötzC, and the capability for
compensation for the presumed depressant effect of DAMGO on
preBötzC inspiratory neurons, was greater than in the isolated in vitro
preparations. Since studies were not completed in anesthetized goats,
we have no direct evidence of greater compensation after DAMGO
injections in the awake versus anesthetized state. Certainly,
compensation or plasticity can occur within the respiratory network, as
indicated by our findings (after the DAMGO studies) of a normal
respiratory rhythm and pattern in this same group of goats after neartotal, incremental destruction of the presumed preBötzC area.13 The
capability for compensation may, however, be limited or differ
between conditions that could account for our findings in the awake
goat that DAMGO attenuated the ventilatory responses during the
stressed conditions of hypoxia and hypercapnia. The possibility of
greater compensation in the awake state is also suggested by the
findings in adult rats that administration of a μ-opioid to the preBötzC
slowed respiratory rate in anesthetized and NREM sleep states but not
in the awake state.19 If indeed compensation occurs with depression of
the preBötzC, it appears unlikely that compensation occurred through
increased contribution of expiratory muscles, because abdominal
expiratory muscle activity did not change after the injection of DAMGO
(Figs. 6 and 7).
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